About Codex Oncology

About company

Codex Oncology Ltd is developing novel anti-cancer therapeutics. The Company’s business model is to advance these drug molecules to Investigational New Drug Status and carry out pre-clinical trials. The Software platform allows users drug molecules and can suggest potential drug molecules that can bind to these sites specifically. This can reduce the length of time to reach the clinic and, therefore, reduce the overall cost of the drug development process.